Abnormal Uterine Bleeding

Abnormal Uterine Bleeding (CPG)
 Significant deviation from the normal duration, volume, regularity, frequency of menses
Duration of flow
 Normal: 4.5-8 days
 Prolonged: >8 days
 Shortened: <4.5 days
Frequency of menses
 Normal: 24-38
Volume of monthly blood loss
 Normal: 5-80ml
Regularity of menses
 Variation: 2-20 days
Heavy abnormal bleeding

 Used to replace the term menorrhagia
Dysfunctional uterine bleeding
 Heavy bleeding that is not due to complications of pregnancy or systemic or local pelvic pathology
 However this term is discarded by POGS
 Ovulatory DUB
o Regular cycles with heavy bleeding
 Anovulatory DUB
o Irregular, prolonged and/or heavy bleeding
Abnormal uterine bleeding
 This includes DUB and bleeding from organic causes
 Organic etiology
o Bleeding due to systemic causes or disorders of reproductive tract
 DUB
o Bleeding not due to organic causes
Acute AUB
 Ranges from moderate to heavy bleeding that causes significant blood loss leading to hypovolemia
(hypotension and tachycardia) and/or shock
Chronic AUB
 Bleeding from uterine corpus that is abnormal in volume, duration, regularity, and/or frequency and has
been present for >6 months
Pathophysiology
Normal hemostasis is achieved by:
 Stabilization of hemostatic platelet plug
 Higher thromboxane (PGF) to prostacyclin (PGE2) level
 Fibrin clot formation
Absence of any of the three causes AUB
Doc Pareja’s lecture
Vaginal bleeding
 Most common gynecologic complaint of women
 Reproductive age incidence- 3-30%
Abnormal uterine bleeding- any significant deviation to the normal duration, frequency, volume, flow of menstrual
bleeding
Heavy menstrual bleeding- replaced the term menorrhagia
Intermenstrual bleeding- bleeding occurring in between cycles
Dysfunctional uterine bleeding- basket diagnosis that has been discarded and is now under AUB
Criteria for abnormal uterine bleeding

Frequency: normal- 24-38 days
Duration: normal- 4-8 days
Flow: 5-80
Regularity: variation of 2-20 days
Heavy menstrual bleeding- is not quantified, as long as the bleeding is something that affects quality of life
PALM COEIN
Palm- structural abnormalities causing AUB
Polyps- occur in all ages but more common in older women
 Diagnosis by ultrasound or hysteroscopic imaging without histopath
 Seen as tongue-like protrusion
Adenomyosis- abnormal stromal and endometrial gland proliferation causing smooth muscle hyperplasia and
hypertrophy
 Can be diffused affecting all of the uterus or localized affecting only one part
 There is no delineation of endometrium from myometrium
 Pathophys:
o Hampered myometrial contractions
o Abnormal PGF/PGE ratio
o Increased endometrial surface
o Abnormal endometrial angiogenesis
 Types: presence of 2 or more highly associates with adenomyosis
o A- assymetric thickening
o B- myometrial cysts
o C- hyperechoic islands
o D- fan shaped shadowing
o E- echogenic lines and buds
o F- translesional vascularity
o G- irregular junctional zone
o H- interrupted junctional zone
Leiomyoma- aka fibroids

 Overgrowth of smooth muscle and connective tissue in the uterus
 Four types
o Intramural- within muscle or myometrium
o Intraserosal- closer to outer surface
o Parasitic- independent of the uterus
o Submucosal- within cavity, highly vascularized and difficult to stop with just myometrial contractions
 Presentation: heavy menstrual bleeding
 Results from
o Myoma interfering with normal hemostasis
o Increased endometrial surface
o Mechanical compression of venous drainage
o Dilation of venous plexuses draining the endometrium
o Ulceration and hemorrhage of endometrium
Malignancy- premalignant hyperplasia or malignant process
COEIN- nonstructural causes of AUB

Coagulopathy- bleeding disorders
 Von willebrand disease- most common coagulopathy causing AUB
 No longer indicates pharmacologic causes of bleeding
Ovulatory dysfunction- usually related to endocrinopathies
 Anorexia, weight loss, hypothyroidism, hyperprolactinemia
Endometrial dysfuction- not related to any endocrinopathies
 d/t deficiencies in production of local vasoconstrictors and accelerated lysis of endometrial clots
Iatrogenic- irregular or breakthrough bleeding
 may be due to use of OCPs or pharmacologic agents that cause bleeding
 steroids, IUDs, tranquilizers
Not otherwise classified- poorly defined and inadequately examined
 arteriovenous malformation, cesarean section niche or defect, myometrial hypertrophy
women with normal blood loss will tend to:

 interval between menstrual pad change is >3 hours
 tampon usage in one cycle is <21
 does not need to change pad at night
 not anemic
 passage of clots less than 1 cm
criteria to classify a person as having coagulopathy disorder as the cause of AUB

1 of any:
 postpartum hemorrhage
 surgical bleeding
 bleeding associated with dental work
2 of any:
 epistaxis
 frequent bruising
 bleeding gums
 family history of bleeding
PE: identify structural pathology or systemic disease as cause of AUB
Labs
 CBC with platelets- to check for anemia
 Pregnancy test
 PT, PTT, fibrinogen- for those positive with bleeding disorders
 Female hormone testing- not routinely done
 Thyroid screening- done in those only showing thyroid s/s
Imaging
 Ultrasound- first line diagnostic
 Transvaginal ultrasound- done in days 4-6 of menstrual cycle for more accuracy
o Can identify PALM causes of AUB
 Saline infusion- not first line
o Better suited for intracavitary lesions
 Hysteroscopy- done when ultrasound findings are inconclusive
Acute uterine bleeding- bleeding in a nonpregnant women of reproductive age occuring more than 7 days
 More common in anovulatory women
 Range from moderate to severe leading to hypovolemia (hypotension and tachycardia) and anemia
 Goal of treatment: build up endometrium with estrogen for hemostasis and progestins for endometrial
stability
Medical management- should be done first before surgical management unless bleeding is due to submucosal
myomas
 High dose conjugate equine estrogen- 25 mg IV CEEq4h to stop bleeding
 High dose COC in tapered doses
 Progestin- MPA 10mg TID for 7 days
 Tranexamic acid 1gm q6h
Definitive treatment: proceed once bleeding is controlled and anemia is corrected
 Palm causes- treat structural causes
 Coagulopathy- treat bleeding disorder
 Ovulatory- treat endocrine pathology
 Iatrogenic- remove item causing the bleeding
Surgical management
 D and C- not recommended as it is only temporary in stopping bleeding
Endometrial biopsy
Indications:
 Age >40 years old
 Risk factors for endometrial cancer: obesity
 Patients on tamoxifen
 Patients refractory to medical management
 Infrequent menses suggestive of anovulatory cycle
Endometrial cancer risk factors:
 Age more than 45
 Endometrial thickness >4mm
 Obesity
 Lynch syndrome
 Chlamydia trachomatis
Risk factors:
Major- long unopposed exposure to estrogen
 Hereditary nonpolyposis colon ca
 Estrogen producing tumor
Minor
 Obesity, nulliparity, PCOS,history of infertility, tamoxifen, nulliparity
Endometrial ablation- for women not desirous for contraception

Hysterectomy- should not eb first line in surgical management
 Indicated only when: failed medical management, not desirous of pregnancy, severelt affects quality of life
Chronic AUB
 LVG-IUS
 COC qlaira- estradiol valerate and dienogest
 Danazol and GNRH agonist- failed medical tx
Comprehensive Gynecology by LOBO

Abnromal uterine bleeding
 35mL- average blood loss per cycle
 >80mL- considered heavy menstrual bleeding
Polyps- proliferation of endometrial glands, stroma, with epithelium
 Common in reproductive women
 Due to estrogen
 Not seen in premenarche women
 Diagnosis based on ultrasonography or heteroscopy with or without histopathology
Adenomyosis- endometrial tissue in the myometrium
 Peak incidence at 5th decade of life
 Multiparity- most significant risk factor
Vulvovaginal disorders
Prepubertal
 Genital warts- suspect for possibility of abuse
 Tight hymenal ring- inability to insert tampon
o Manage with manual dilation and small incision of 6 and 8 o’clock ring
Pelvic masses

Abnormal Uterine Bleeding

Uploaded by

Copyright:

Available Formats

Abnormal Uterine Bleeding

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Abnormal Uterine Bleeding

Uploaded by

Copyright:

Available Formats

Abnormal Uterine Bleeding (CPG)

Heavy abnormal bleeding

Criteria for abnormal uterine bleeding

Leiomyoma- aka fibroids

COEIN- nonstructural causes of AUB

women with normal blood loss will tend to:

criteria to classify a person as having coagulopathy disorder as the cause of AUB

Endometrial ablation- for women not desirous for contraception

Comprehensive Gynecology by LOBO

You might also like

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.